Why Choose Private Prescription for Mounjaro vs Wegovy?
Private vs NHS Route for Mounjaro and Wegovy Access
The NHS pathway for both Mounjaro and Wegovy requires GP referral to specialist weight management services, often involving 6+ month waiting lists and strict eligibility criteria. Private prescription eliminates these barriers entirely. Through EverydayMeds, patients access the same genuine medications - Novo Nordisk Wegovy and Eli Lilly Mounjaro - without waiting lists or referral requirements. Our streamlined process connects you directly with qualified prescribers who can assess your suitability for either treatment.
Private prescription also offers flexibility in treatment choice that NHS pathways may not provide. While NHS protocols often dictate specific treatment sequences, private patients can work with prescribers to choose between Mounjaro's dual GIP/GLP-1 mechanism or Wegovy's established GLP-1 approach based on individual preferences, lifestyle factors, and clinical history. This personalised approach ensures optimal treatment matching from the start.
Mounjaro vs Wegovy Pricing and Value Comparison
Wegovy pricing through EverydayMeds starts at £79.99 for the 0.25mg starter pen, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout to access these prices. Bundle options include the Intro Duo (0.25mg & 0.5mg) for £169.99 and the Ultimate Stability Trio (three 2.4mg pens) for £649.99, providing convenient multi-month supply.
Mounjaro pricing follows a similar escalation structure, though specific costs vary by dose strength. Both medications require prescription fees and clinical assessment costs, but private prescription eliminates hidden NHS pathway costs like multiple GP appointments, specialist consultations, and time off work for lengthy clinic visits. Returning customers benefit from discount code DOSE25, making ongoing treatment more affordable while maintaining the same pharmaceutical quality as NHS-supplied medications.
Clinical Evidence: Mounjaro and Wegovy Trial Data
Wegovy's efficacy stems from the STEP clinical trial programme, where patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained clinically studied weight loss at two years, while SELECT trial data showed 20% reduction in major cardiovascular events.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, demonstrating tirzepatide's dual GIP/GLP-1 mechanism in weight management contexts. Both medications require ongoing use alongside reduced-calorie diet and increased physical activity, with weight regain observed when treatment discontinues. Individual results vary, and neither medication ensures specific weight loss outcomes.
How Wegovy Works vs Mounjaro's Dual Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones responsible for blood sugar regulation and appetite control. It reduces appetite by acting on brain centres that control hunger, promotes feelings of fullness after smaller meals, and may reduce food cravings throughout the day. Mounjaro contains tirzepatide, targeting both GLP-1 and GIP receptors simultaneously - a dual agonist approach that may offer enhanced metabolic benefits. Both work by slowing gastric emptying, meaning food stays in the stomach longer, contributing to sustained satiety between meals.
Private Prescription Ordering Process for Both Medications
EverydayMeds' ordering process begins with a 3-minute online clinical assessment covering medical history, current medications, weight management goals, and contraindication screening. Qualified prescribers registered with GPhC #9012878 review submissions within standard 3 working days, with express 24-hour review available for urgent cases. Once approved, both Mounjaro and Wegovy ship via temperature-controlled cold-chain delivery, arriving next working day in discrete packaging. The entire process from assessment to delivery typically completes within 5 days, compared to months via NHS pathways.
Storage and Practical Differences Between Mounjaro and Wegovy
Both medications require refrigeration at 2-8°C before first use, but Wegovy offers superior travel convenience with 6 weeks room temperature storage (below 30°C) once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both use pre-filled injection pens - Wegovy's FlexTouch pen and Mounjaro's similar auto-injector design. Dose escalation schedules differ: Wegovy follows a 4-week escalation pattern (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) while Mounjaro uses different increments and timing. Weekly injection timing remains consistent for both treatments, administered on the same day each week.
Why Private Prescription Suits Mounjaro vs Wegovy Decisions
Private prescription allows direct consultation about mechanism preferences without NHS pathway restrictions. Some patients prefer Wegovy's established GLP-1 approach with extensive real-world evidence, while others favour Mounjaro's innovative dual-receptor targeting. Private prescribers can discuss these nuances without formulary limitations that may restrict NHS choices.
Cost transparency also benefits decision-making - private patients know exact treatment costs upfront, enabling informed financial planning for long-term weight management. NHS patients may face unexpected charges, prescription fee changes, or treatment switches based on availability rather than clinical preference. Private prescription ensures treatment continuity and choice consistency throughout the weight management journey.
Get Started with Mounjaro or Wegovy Today
Both Mounjaro and Wegovy are available through EverydayMeds' private prescription service, with qualified prescribers ready to help determine which treatment aligns with your individual needs and circumstances. New customers use discount code FIRST40 at checkout, while returning patients apply DOSE25 for ongoing savings. Our clinical assessment takes just 3 minutes, prescriber review completes within 72 hours, and next-day delivery ensures rapid treatment access. Start your weight management journey today at https://everydaymeds.co.uk/collections/wegovy - because effective treatment shouldn't wait for NHS timelines.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
